SCR-LIP-000182 · Claim · machine-readable JSON →
This review of surgical lymphology describes lymph-sparing liposuction (AMLD/Lymphological Liposculpture) for lipohyperplasia dolorosa as eliminating intractable pain and reducing limb circumference while obviating the need for lifelong complete decongestive therapy (CDT/TDC), framing surgery as an option when conservative measures fail.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- very low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- Surgical lymphology. Therapy option for lymphoedema and lipohyperplasia dolorosa — Cornely (2023) ✓ verified — contextual · review · 2023 · reading confidence: high
“objetivos — redução de circunferência, eliminação da necessidade de TDC vitalício, eliminação de dor intratável conservadoramente”
The article is a narrative review focused on surgical treatments (LVA, VLNT, lymph-sparing liposuction) for lymphedema and lipedema. It mentions CDT/TDC only as the conservative standard that surgery aims to render unnecessary, rather than [grade capped low->very_low per curated Oxford N6]
Context (PECO)
Answers these questions
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-05-31 — created · auto-ingested for SQ-LIP-000021